INDRAYANI BIOTECH LTD.
BSE: 526445
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 5.20-12.3% | 5.93-11.3% | 6.69-28.0% | 9.28+13.4% | 8.19-13.9% | 9.51-11.9% | 10.79 |
| Other Income | 0.68-62.9% | 1.82+104.5% | 0.89-4.5% | 0.93+41.1% | 0.66-26.0% | 0.89-13.2% | 1.03 |
| Total Income | 5.88-24.2% | 7.75+2.3% | 7.58-25.8% | 10.22+15.4% | 8.85-14.9% | 10.40-12.0% | 11.82 |
| EXPENSES | |||||||
| Expenditure | 5.77-19.1% | 7.13-3.8% | 7.41-26.0% | 10.01+15.0% | 8.71-15.2% | 10.27-11.9% | 11.65 |
| Tax | 0.03-82.9% | 0.16+270.7% | 0.04 | 0.00-100.0% | 0.04+9.1% | 0.03-17.5% | 0.04 |
| PROFIT | |||||||
| PBT | 0.11-82.9% | 0.63+267.8% | 0.17-15.9% | 0.20+42.5% | 0.14+7.6% | 0.13-22.4% | 0.17 |
| Net Profit | 0.08-82.9% | 0.47+266.8% | 0.13-36.9% | 0.20+90.9% | 0.11+7.1% | 0.10-23.8% | 0.13 |
| KEY METRICS | |||||||
| OPM % | 12.80%+13.48pp | -0.68%-11.91pp | 11.23%-7.37pp | 18.60%+47.52pp | -28.92%+2.27pp | -31.19%-32.77pp | 1.58% |
| NPM % | 1.36%-4.68pp | 6.04%+4.35pp | 1.69%-0.29pp | 1.98%+0.78pp | 1.20%+0.25pp | 0.95%-0.25pp | 1.20% |
| EPS | 0.01-90.0% | 0.10+233.3% | 0.03 | 0.00-100.0% | 0.02+0.0% | 0.02 | 0.00 |
Corporate Events
Board Meeting
To consider and approve a proposal for the demerger of a uni…
BSE Filing ↗Board Meeting
To consider and formally accept the resignation of Mr. Indi…
BSE Filing ↗Board Meeting
To consider and approve the unaudited financial results (Sta…
BSE Filing ↗Board Meeting
consider and approve unaudited financial results (standalone…
BSE Filing ↗Board Meeting
Reappointment of Mr. Swaminathan as Whole-time director for …
BSE Filing ↗Board Meeting
Consider and approve the audited financial results (standalo…
BSE Filing ↗Board Meeting
consider and approve audited financial results (standalone &…
BSE Filing ↗Board Meeting
Consider and approve amendments in the terms of .... Regulat…
BSE Filing ↗Board Meeting
Unaudited Financial Results (Standalone and Consolidated) of…
BSE Filing ↗Board Meeting
Intimation of Board Meeting, approval of increase and reclas…
BSE Filing ↗Board Meeting
Consideration and approval of Unaudited Financial Results (S…
BSE Filing ↗Board Meeting
Approval to increase authorised share capital, amend Article…
BSE Filing ↗Board Meeting
Consideration and approval of Unaudited Financial Results (S…
BSE Filing ↗Board Meeting
Recommendation of Payment of dividend on 12% Compulsorily Co…
BSE Filing ↗Board Meeting
Consideration and approval of Unaudited Standalone and Conso…
BSE Filing ↗